Product Description
Pamorelin 22.5 Mg Injection is a sought-after, valuable medication indicated for advanced prostate cancer, breast cancer, endometriosis, uterine fibroids, and precocious puberty. Formulated with Triptorelin pamoate, this depot injection offers a sustained release and is administered intramuscularly every 3 months. Each pack contains one vial (22.5 mg) and a solvent ampoule, ensuring precise dosing. Limited time promotion available for advance purchase! Marketed by Ipsen Pharma and registered under DCGI, Pamorelin has been remarked for its clinical efficacy, making it a preferred choice among healthcare providers in India.
Versatile Application and Features of Pamorelin 22.5 Mg Injection
Pamorelin 22.5 Mg Injection is designed for versatile use in hospitals, specialty clinics, oncology centers, and gynecology practices, particularly in India. The primary application media include direct intramuscular injection, utilizing the provided powder and solvent for optimal reconstitution. Notably, Pamorelin features a depot formulation, ensuring sustained drug release and effectiveness with each three-month dose. Its odorless, stable powder must be refrigerated, providing reliability and extended shelf life in demanding medical environments.
Pamorelin 22.5 Mg Injection Sample Policy and Quick Supply
Pamorelin 22.5 Mg Injection samples are available for healthcare institutions following receipt of a purchase order. Our streamlined supply ability ensures quick dispatch and efficient handling, supported by reliable transport services across India. Samples are provided in standard packaging for evaluation and clinical assessment. For all bulk or repeat orders, prompt delivery and carefully managed logistics minimize delays, supporting medical professionals in maintaining continuous treatment availability for valued patients.
FAQs of Pamorelin 22 5 Mg Injection:
Q: How is Pamorelin 22.5 Mg Injection administered?
A: Pamorelin 22.5 Mg Injection is given as an intramuscular injection, typically every three months, by a trained healthcare professional.
Q: What are the primary indications for using Pamorelin?
A: Pamorelin is primarily indicated for the treatment of advanced prostate cancer, advanced breast cancer, endometriosis, uterine fibroids, and precocious puberty.
Q: When should Pamorelin be stored and used after reconstitution?
A: Pamorelin should be stored refrigerated between 2C and 8C and used immediately after reconstitution to ensure maximum effectiveness.
Q: Where can Pamorelin 22.5 Mg Injection be applied?
A: This injection is commonly used in hospitals, oncology clinics, and specialized health care facilities across India.
Q: What benefits does the depot formulation of Pamorelin offer?
A: Pamorelins depot formulation provides sustained release of the active ingredient, reducing dosing frequency to once every three months and ensuring consistent therapeutic levels.
Q: How can healthcare providers obtain a sample of Pamorelin 22.5 Mg Injection?
A: Healthcare providers can request a sample through a formal purchase order, and samples are dispatched quickly with reliable transport services.